Sulfadimethoxine
正在补全数据,稍后刷新页面可查看最新内容
122-11-2COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1ZZORFUFYDOWNEF-UHFFFAOYSA-NSulfadimethoxine is a sulfonamide consisting of pyrimidine having methoxy substituents at the 2- and 6-positions and a 4-aminobenzenesulfonamido group at the 4-position. It has a role as an antimicrobial agent, an antiinfective agent, a xenobiotic, an environmental contaminant and a drug allergen. It is a sulfonamide, an aromatic ether, a member of pyrimidines, a substituted aniline and a sulfonamide antibiotic. It is functionally related to a sulfanilamide.
Pharmaceuticals -> Antibiotics (Sulfonamide)
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Antibiotics
FDA approved animal drugs -> Active ingredient
Pharmaceuticals -> UK Veterinary Medicines Directorate List
Pharmaceuticals -> Animal Drugs -> Approved in Taiwan
Positive
2.74
2.7
Agilent XCT
Electrospray ionization
formic acid (5.3nM)
173.09 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
166 Ų [M+H]+ [CCS Type: TW]
170.5 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]
167.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
171.3 Ų [M-H]-
安全信息仅供参考,不能替代供应商安全技术说明书(SDS)、适用法规与专业评估。
This chemical does not meet GHS hazard criteria for 4.4% (5 of 113) of reports.
Warning
H315 (46%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P272, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 113 reports by companies from 11 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Sulfadimethoxine
Pharmaceutical
Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP
J01ED02
J - Antiinfectives for systemic use
QP - Antiparasitic products, insecticides and repellents
QJ - Antiinfectives for systemic use
Pharmaceuticals -> Antiinfectives for systemic use -> Antibacterials for systemic use -> Sulfonamides and trimethoprims -> Long-acting sulfonamides -> Antibiotics
Pharmaceuticals -> Animal Drugs -> Approved in Taiwan
用途抗菌作用、临床疗效与SD相似。内服吸收迅速而排泄较慢,作用维持时间长,体内乙酰化率低,不易引起泌尿道损害。本品除有广谱抗菌作用外,尚有显著的抗球虫、抗弓形体作用。主要用于防治犊牛、鸡、兔球虫病,亦用于防治鸡传染性鼻炎、禽霍乱、卡氏住白细胞原虫病、猪狗的弓形体病(常与乙胺嘧啶合用)及狗、猫的诺卡菌病,还可用于防治细菌性烂鳃病、竖鳞病、鱼类弧菌病、鳗赤鳍病、鲤科鱼类疖疮病等。
用途通过抑制二氢叶酸合成酶阻断二氢叶酸合成的磺胺类抗生素。 作用方式:在原核生物中抑制叶酸合成。 抗菌谱:革兰氏阳性菌、革兰氏阴性菌、衣原体 抗性机理:二氢叶酸合成酶或叶酸合成替代路径的改变。
生产方法在2000L反应釜中加入600kg甲醇、348.5kg缩合产物及440kg 20%氢氧化钠溶液,搅拌并升温至85℃回流反应6小时。反应完成后,将反应液冷却至10℃以下,缓慢滴加20%盐酸溶液调节pH至6.7。继续冷却至0℃,离心分离得到粗品磺胺二甲氧嘧啶(SDM)。将粗品溶于800kg甲醇中,加入15kg活性炭,加热回流0.5小时进行脱色处理,趁热压滤。滤液冷却至0℃后离心,干燥得到294.6kg磺胺二甲氧嘧啶(SDM),收率96%,纯度99%。参考文献:[1] Patent: CN107325057, 2017, A. Location in patent: Paragraph 0027; 0028; 0035; 0036; 0040; 0041; 0045; 0046[2] Monatshefte fuer Chemie, 1956, vol. 87, p. 136,142
122-11-2DTXSID1023607CHEMBL62193CHEBI:32161